Condition: Early-stage Breast Cancer · Breast Carcinoma in Situ · Breast Neoplasms · Sponsor: Saint John's Cancer Institute
This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.
This description comes directly from the study's public registry record.
Janie Grumley, MD · (310) 582-7100 · janie.grumley@providence.org
Always discuss trial participation with your own doctor first.
| John Wayne Cancer Institute, Providence Saint John's Health Center | Santa Monica, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04603209